A review of clinical guidelines on the management of iron deficiency and iron-deficiency anemia in women with heavy menstrual bleeding

D Mansour, A Hofmann, K Gemzell-Danielsson - Advances in therapy, 2021 - Springer
Introduction Up to one-third of women of reproductive age experience heavy menstrual
bleeding (HMB). HMB can give rise to iron deficiency (ID) and, in severe cases, iron …

The prevalence of menstrual cycle disorders and menstrual cycle-related symptoms in female athletes: a systematic literature review

BC Taim, C Ó Catháin, M Renard, KJ Elliott-Sale… - Sports Medicine, 2023 - Springer
Background Menstrual cycle (MC) disorders and MC-related symptoms can have debilitating
effects on the health and performance of female athletes. As the participation of women in …

Abnormal uterine bleeding in perimenopausal women: the role of hysteroscopy and its impact on quality of life and sexuality

SG Vitale, R Watrowski, F Barra, MN D'Alterio… - Diagnostics, 2022 - mdpi.com
Abnormal uterine bleeding (AUB) is a frequent symptom in perimenopausal women. It is
defined as uterine bleeding in which the duration, frequency, or amount of bleeding is …

[HTML][HTML] From menarche to menopause, heavy menstrual bleeding is the underrated compass in reproductive health

S Vannuccini, V Jain, H Critchley, F Petraglia - Fertility and sterility, 2022 - Elsevier
Menstruation is defined as monthly uterine bleeding, regarded as a sign of reproductive
health. When characterized by excessive bleeding (heavy menstrual bleeding [HMB]), it may …

Efficacy of a vaginal suppository formulation prepared with Acacia arabica (Lam.) Willd. gum and Cinnamomum camphora (L.) J. Presl. in heavy menstrual bleeding …

MJA Fazmiya, A Sultana, MBB Heyat… - Frontiers in …, 2024 - frontiersin.org
Objective: This study aims to determine the efficacy of the Acacia arabica (Lam.) Willd. and
Cinnamomum camphora (L.) J. Presl. vaginal suppository in addressing heavy menstrual …

[HTML][HTML] Contraceptive efficacy and safety of the 52-mg levonorgestrel intrauterine system for up to 8 years: findings from the Mirena Extension Trial

JT Jensen, E Lukkari-Lax, A Schulze, Y Wahdan… - American journal of …, 2022 - Elsevier
Background The 52-mg levonorgestrel-releasing intrauterine system is an established, long-
acting contraceptive option with approved use for up to 7 years. Objective The Mirena …

Prevalence of heavy menstrual bleeding and associations with physical health and wellbeing in low-income and middle-income countries: a multinational cross …

SS Sinharoy, L Chery, M Patrick, A Conrad… - The Lancet Global …, 2023 - thelancet.com
Background Data on the prevalence of heavy menstrual bleeding in low-income and middle-
income countries (LMICs) are scarce. We aimed to assess the validity of a scale to measure …

Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research to advance the health of people with …

MK Baldwin, HK Ahmadzia, DL Bartlett… - Expert review of …, 2023 - Taylor & Francis
Background People who have or had the potential to menstruate (PPM) with inherited
bleeding disorders (BD) face particular challenges receiving appropriate diagnosis and care …

Association of levonorgestrel intrauterine devices with stress reactivity, mental health, quality of life and sexual functioning: A systematic review

Z Bürger, AM Bucher, E Comasco, M Henes… - Frontiers in …, 2021 - Elsevier
Abstract Levonorgestrel-intrauterine-devices (LNG-IUD) are one of the most used
contraceptive methods worldwide. While several reviews exist on how LNG-IUDs impact …

Determinants and assessment of menstrual blood flow

J Liang, F Ali, M Ramaiyer, MA Borahay - Current epidemiology reports, 2023 - Springer
Abstract Purpose of Review The modifiable and non-modifiable determinants and the
currently available methods of assessment of menstrual blood flow will be discussed, with …